Loading...

FREDUN Fredun Pharmaceuticals Ltd Expansion Plans Announcement

Frdn

FRDN

Fredun Pharmaceuticals Ltd

(FREDUN)

2026 Announcement

Regulatory Compliance Update

AGM Book Closure

Annual Report & AGM Notice

Earnings Conference Call

Earnings Conference Call

AGM via VC/OAVM

Annual Secretarial Compliance

Newspaper publication

Auditors Appointments

Share capital increase and ...

Product launches and capaci...

Dividend declaration and ca...

Financial Statements

New Product Launch

New Product Launch

Regulatory monitoring report

Manufacturing expansion

Regulatory disclosure

Equity Investment Disclosure

Promoter Allotment

Promoter warrant conversion

Regulatory Compliance

Trading Window Closure

Promoter holding change

Analyst / Institutional Mee...

Warrant conversion to equity

Warrants conversion to equity

Analyst/Investor Meeting

Investor Meeting

Analyst/Institutional Inves...

Conference Schedule

Credit Rating Upgrade

Earnings Conference Call

Fund utilization deviation

Monitoring Agency Report

Financial Results

Un-audited financial results

Earnings Call Invite

Unaudited Financial Results

Un-Audited Financial Results

Book closure for EGM

EGM date notice

Regulatory Compliance

Trading window closure

Equity Offering

Preferential allotment

Equity investment details

Preferential allotment

Analysts/Investors Call

Virtual Investor Meet

Preferential Issue Details

Appointments of Directors

Independent Director Appoin...

Appointment of Independent ...

Earnings Call Transcript

Conference Call Recording

Newspaper advertisement

61% EBITDA Growth

Revised Financial Results

Earnings Call Notice

Board Meeting Scheduled

New Pet Product

SEBI Compliance Certificate

Strategic Acquisition

Independent Directors Retire

EOGM Announcement

Management Changes

Management Change

EGM Announcement

AGM Announcement

Annual General Meeting

Investor Meeting Update

Investor Meeting

Q1 FY26 Results

Earnings Call Audio

Earnings Call Recording

Strong Profit Growth

New Directors Appointed

Management Changes

Management Change

Earnings Call Announcement

Earnings Call Notice

SEBI Order Update

Compliance Certificate

SEBI Order No Penalty

Pet Care Acquisition

Leadership Loss

Investor Presentation

Investor Presentation

Financial Results Update

Strong Q4 Performance

Management Changes

Compliance Update

Management Change

Management Appointment

Compliance Submission

Credit Rating Upgrade

Freossi Launches Sri Lanka

Large Animal Segment

Internal Auditor Appointed

Management Change

Management Change

Strong Q3 Performance

New Subsidiary Formed

Production Capacity Boost

Compliance Certificate

Vet Diagnostic Center

New Pet Facility

SEBI Compliance Certificate

Fundraising Announcement

Fundraising Announcement

Annual General Meeting

AGM Announcement

Compliance Certificate Subm...

Compliance Submission

Financial Results Approval

Financial Results FY24

Pharma Certificate Submission

Compliance Certificate Subm...

Expansion and Product Devel...

Certificate Submission

General Meeting Advertisement

Meeting Announcement

Management Re-appointment

Fundraising Proposal

Change in Management

Certificate Submission

Appointment Call-off

Product Launches

Clarification on Price Move...

Financial Statements

Appointments, Resignations

Preferential Issue

Financial Statements

Annual Compliance Report

Publication of Results

Appointments/Re-appointment...

Earnings Releases

Equity Allotment

External Links:

Data:

Fredun Pharmaceuticals reports FY26 revenue ₹639.12 cr, EBITDA ₹94.79 cr, and PAT ₹33.21 cr, with new hormone and NAD+ platforms, plus Palghar facility expansion and a credit rating upgrade to IVR BBB+ (Stable).

AI Assistant

Fredun Pharmaceuticals Ltd

2026

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.